title: Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
abstract: Human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte (CTL) responses play a major role in the antiviral immune response, but the relative contribution of CTL responses restricted by different HLA class I molecules is less well defined. HLA-B60 or the related allele B61 is expressed in 10 to 20% of Caucasoid populations and is even more highly prevalent in Asian populations, but yet no CTL epitopes restricted by these alleles have been defined. Here we report the definition of five novel HLA-B60-restricted HIV-1-specific CTL epitopes, using peripheral blood mononuclear cells in enzyme-linked immunospot (Elispot) assays and using CTL clones and lines in cytolytic assays. The dominant HLA-B60-restricted epitope, Nef peptide KEKGGLEGL, was targeted by all eight subjects with B60 and also by both subjects with B61 studied. This study additionally establishes the utility of the Elispot assay as a more rapid and efficient method of defining novel CTL epitopes. This approach will help to define new CTL epitopes that may play an important role in the immune control of HIV-1.
authors.affiliation: Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Altfeld
authors.forename: A
authors.initials: A
authors.lastname: Trocha
authors.forename: R L
authors.initials: RL
authors.lastname: Eldridge
authors.forename: E S
authors.initials: ES
authors.lastname: Rosenberg
authors.forename: M N
authors.initials: MN
authors.lastname: Phillips
authors.forename: M M
authors.initials: MM
authors.lastname: Addo
authors.forename: R P
authors.initials: RP
authors.lastname: Sekaly
authors.forename: S A
authors.initials: SA
authors.lastname: Kalams
authors.forename: S A
authors.initials: SA
authors.lastname: Burchett
authors.forename: K
authors.initials: K
authors.lastname: McIntosh
authors.forename: B D
authors.initials: BD
authors.lastname: Walker
authors.forename: P J
authors.initials: PJ
authors.lastname: Goulder
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D002648:Child; D000939:Epitopes; D015683:Gene Products, gag / Q000276:immunology; D015693:Gene Products, nef / Q000276:immunology; D015488:HIV Antigens / Q000276:immunology; D016655:HIV Core Protein p24 / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D015235:HLA-B Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D008969:Molecular Sequence Data; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus; D054311:nef Gene Products, Human Immunodeficiency Virus
chemical_list: D000939:Epitopes; D015683:Gene Products, gag; D015693:Gene Products, nef; D015488:HIV Antigens; D016655:HIV Core Protein p24; D015700:HIV Envelope Protein gp41; D015235:HLA-B Antigens; C081918:HLA-B60 antigen; C079077:HLA-B61 antigen; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus; D054311:nef Gene Products, Human Immunodeficiency Virus; C054858:p17 protein, Human Immunodeficiency Virus Type 1